biostudies-literaturePresley CJNCATS NIH HHSNIA NIH HHSNCI NIH HHSNational Institute on Aging101844https://www.ebi.ac.uk/biostudies/studies/S-EPMC11701799biostudies-literatureUnknown15(7)<h4>Introduction</h4>Novel supportive care interventions designed for an aging population with lung cancer are urgently needed. We aimed to determine the feasibility of a novel supportive care physical therapy (PT) plus progressive muscle relaxation (PMR) intervention delivered to older adults with advanced lung cancer in the United States (US).<h4>Materials and methods</h4>This clinical trial, Resiliency Among Older Adults Receiving Lung Cancer Treatment (ROAR-LCT: NCT04229381), recruited adults aged ≥60 years with unresectable stage III/IV non-small cell (NSCLC) or small cell lung cancer (SCLC) receiving cancer treatment at The James Thoracic Oncology Center (planned enrollment, N = 20). There were no exclusion criteria pertaining to performance status, laboratory values, prior cancer diJournal of geriatric oncologyResiliency among older adults receiving lung cancer treatment (ROAR-LCT): A novel supportive care intervention for older adults with advanced lung cancer.PMC11701799K76 AG074923K12 CA133250P30 CA016058K01 AG070310P30 AG021342R03 AG064374UL1 TR001863Grogan MCarbone DPCompston AWilliams NAllore HAndersen BLFocht BKnauss BJanse SLo SBRedder EQuist MArrato NAWells-Di Gregorio SPresley CJHoyd RPaskett EDBenedict JSpakowicz DHock KGill TMHayes SfalseResiliency among older adults receiving lung cancer treatment (ROAR-LCT): A novel supportive care intervention for older adults with advanced lung cancer.<h4>Introduction</h4>Novel supportive care interventions designed for an aging population with lung cancer are urgently needed. We aimed to determine the feasibility of a novel supportive care physical therapy (PT) plus progressive muscle relaxation (PMR) intervention delivered to older adults with advanced lung cancer in the United States (US).<h4>Materials and methods</h4>This clinical trial, Resiliency Among Older Adults Receiving Lung Cancer Treatment (ROAR-LCT: NCT04229381), recruited adults aged ≥60 years with unresectable stage III/IV non-small cell (NSCLC) or small cell lung cancer (SCLC) receiving cancer treatment at The James Thoracic Oncology Center (planned enrollment, N = 20). There were no exclusion criteria pertaining to performance status, laboratory values, prior cancer di2024-01-01T00:00:00Z2024 Sep2026-05-29T07:01:49.145Z2026-04-08T03:52:07.71ZS-EPMC117017993917444910.1016/j.jgo.2024.101844